Secondary bladder cancer after anticancer therapy for prostate cancer: reduced comorbidity after androgen-deprivation therapy

@inproceedings{Shiota2015SecondaryBC,
  title={Secondary bladder cancer after anticancer therapy for prostate cancer: reduced comorbidity after androgen-deprivation therapy},
  author={Masaki Shiota and Akira Yokomizo and Ario Takeuchi and Kenjiro Imada and Keijiro Kiyoshima and Junichi Inokuchi and Katsunori Tatsugami and S. Ohga and Katsumasa Nakamura and H Honda and Shigeru Naito},
  booktitle={Oncotarget},
  year={2015}
}
Radiotherapy for prostate cancer is associated with an increased incidence of secondary bladder cancer (BC). We investigated the incidence, clinicopathological characteristics, and prognosis of BC after radiotherapy, surgical therapy, and primary androgen-deprivation therapy (ADT) for prostate cancer. This study included 1,334 Japanese patients with prostate cancer treated with radiotherapy (n=631), surgical therapy (n=437), and primary ADT (n=266). During the median follow-up period of 51.2… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 11 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 40 REFERENCES

Similar Papers

Loading similar papers…